Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Follea International, a brand under the Daniel Alain umbrella, is a premier manufacturer of high-end human hair wigs and hair enhancements specifically designed for individuals experiencing medical hair loss. The company focuses on providing natural-looking, comfortable solutions for conditions such as alopecia, thinning hair, and chemotherapy-induced hair loss. Follea is recognized for its proprietary craftsmanship, including the use of premium European hair and specialized cap constructions like the Gripper and Style collections. Through its parent company, Daniel Alain, it also integrates scientific research into hair health and hair loss diagnostics, such as the Minoxidil Response Test. The brand is considered a leader in the cranial prosthesis market, often working with medical professionals to support patients' psychological well-being during treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Follea International.